PTYLTD
    • Insights
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Insights

Videos

Pricing

About us

Contact us

  • Home
  • Insights into ASX Stocks
  • By Topic

By Topic

Predictive Discovery (ASX: PDI)

Predictive Discovery (ASX: PDI): Strong Gold Output and Cash Growth Drive the Price Toward Resistance

Aug 14, 2026
Proactive Equities Team

Predictive Discovery has become a cash-generating West African gold producer following its Robex merger. Strong June output, rising cash reserves, Bankan engineering progress and regional expansion are strengthening its growth case, though permitting, cost and execution risks remain.

Arafura Rare Earths (ASX: ARU)

Is Arafura Rare Earths (ASX: ARU) Ready to Make Its Next Move Higher?

May 13, 2026
Proactive Equities Team

Arafura Rare Earths is advancing its Nolans project as a major non-China NdPr supplier, supported by strategic offtakes, sector tailwinds, and improving technical momentum, though investors still face key risks including funding, execution delays, and rare earth price volatility.

Life360 INC. (ASX:360)

Life360 INC. (ASX:360): Stronger Growth, Expanding Margins and a Bullish Channel Under Pressure

Aug 18, 2026
Proactive Equities Team

Life360 delivers powerful subscription and advertising growth, expanding margins and accelerating global penetration. Strong MAU momentum, rising Paying Circles, and a breakout technical setup reinforce the company’s position as a high‑growth digital safety leader.

Pro Medicus (ASX: PME)

Pro Medicus (ASX: PME): Scaling Global Leadership in Enterprise Imaging and AI‑Driven Diagnostics

Aug 19, 2026
Proactive Equities Team

Pro Medicus (ASX: PME) delivers record revenue growth, expanding margins, and accelerating AI‑driven innovation, reinforcing its global leadership in enterprise imaging and cloud‑based diagnostics.

Bannerman Energy (ASX: BMN)

Bannerman Energy (ASX: BMN): Strategic Financing and Etango Execution Momentum

Aug 20, 2026
Proactive Equities Team

Bannerman Energy (ASX: BMN) advances Etango uranium project with CNNC financing, strong early works execution, and rising uranium prices, positioning as a leveraged mid-cap growth play in a buoyant nuclear fuel market.

AVITA Medical INC. (ASX: AVH)

AVITA Medical INC. (ASX: AVH): Technical Rally Driven by Solid Fundamentals

Aug 22, 2026
Proactive Equities Team

AVITA Medical is strengthening its commercial position as revenue growth improves, cash burn reduces, and its regenerative medicine portfolio expands. The company’s progress in product adoption and operational efficiency keeps it positioned as a speculative healthcare growth story.

...

 

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics
Videos

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

1...141516...64
Page 15 of 64